Clearline Capital’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-246,545
Closed -$3.06M 189
2021
Q3
$3.06M Buy
246,545
+128,685
+109% +$1.86M 0.29% 67
2021
Q2
$2.15M Buy
117,860
+693
+0.6% +$13.8K 0.32% 65
2021
Q1
$2.44M Sell
117,167
-136,931
-54% -$2.89M 0.32% 60
2020
Q4
$4.54M Sell
254,098
-196,323
-44% -$2.95M 1.01% 37
2020
Q3
$5.11M Buy
450,421
+411,391
+1,054% +$5.08M 1.34% 24
2020
Q2
$532K Buy
+39,030
New +$537K 0.17% 55

Other funds holding RDUS

Clearline Capital's RDUS Position: Q4 2021 in Review

Clearline Capital sold out of Radius Health, Inc. (RDUS) in Q4 2021, closing a stake of 246,545 shares — an estimated $3.06M sold.

Clearline Capital first reported a position in RDUS in Q2 2020 and held it in 6 quarters. The position peaked at $5.11M in Q3 2020. 135 funds tracked by Wall St. Rank hold RDUS as of Q4 2021.

  • Clearline Capital reported no remaining Radius Health, Inc. position as of Q4 2021 after selling out during the quarter.
  • Clearline Capital sold 246,545 Radius Health, Inc. shares in Q4 2021, an estimated $3.06M.
  • Clearline Capital first reported a position in Radius Health, Inc. in Q2 2020 and held it in 6 quarters.
  • Clearline Capital's Radius Health, Inc. position peaked at $5.11M in Q3 2020.
  • 135 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q4 2021.

Based on Clearline Capital's 13F filing for Q4 2021, filed 14 Feb 2022.